Celiac Disease Testing and Treatment Protocol
The best approach to diagnose celiac disease is to first perform serologic testing with IgA tissue transglutaminase antibody (tTG-IgA) while the patient is on a gluten-containing diet, followed by duodenal biopsies if serology is positive. 1
Diagnostic Algorithm
Step 1: Initial Serologic Testing
- Primary test: IgA tissue transglutaminase antibody (tTG-IgA)
- Sensitivity: 97.7%, Specificity: 70.2% in children 1
- Must be performed while patient is on a gluten-containing diet
- Concurrent test: Check total serum IgA levels
Step 2: Intestinal Biopsy
- Required if serology is positive
- Collection protocol:
- At least 6 specimens total
- 1-2 from duodenal bulb
- At least 4 from distal duodenum 1
- Diagnostic findings:
- Villous atrophy
- Crypt lengthening
- Increased intraepithelial lymphocytes (≥25 IELs per 100 enterocytes) 1
- Classified using Marsh classification system
Step 3: HLA Testing
- HLA-DQ2/DQ8 testing has >99% negative predictive value 1
- Indicated in specific scenarios:
Special Diagnostic Considerations
- For patients already on gluten-free diet without prior diagnosis:
- Resume normal diet with three slices of wheat bread daily for 1-3 months
- Then repeat serologic testing 1
- High tTG-IgA levels (>70 IU/ml or >12 times upper limit) may be sufficient for diagnosis in symptomatic patients without requiring biopsy 2
- First-degree relatives of celiac patients have 7.5% risk of developing the disease 1
- High-risk groups requiring screening:
- Type 1 diabetes
- Autoimmune thyroid disease
- Down syndrome
- Turner syndrome
- Unexplained iron deficiency anemia 1
Treatment Protocol
Step 1: Gluten-Free Diet Implementation
- Strict, lifelong gluten-free diet is the only effective treatment for celiac disease 1, 3
- Immediate referral to dietitian with expertise in celiac disease 1
- Education on hidden sources of gluten and cross-contamination
Step 2: Monitoring and Follow-up
- Serologic follow-up:
- Anti-tTG antibody levels at 6 months
- Repeat at 12 months
- Then annually thereafter 1
- Clinical assessment annually to evaluate:
- Symptom resolution
- Nutritional status
- Weight management
- Development of complications 1
- Evaluation for nutritional deficiencies:
- Iron
- Folate
- Vitamin B12
- Vitamin D 1
Step 3: Management of Non-responsive Celiac Disease
- For patients with persistent symptoms despite adherence to gluten-free diet:
- Refractory celiac disease is rare but has poor prognosis 3
Common Pitfalls and Caveats
Starting gluten-free diet before testing
- Dramatically reduces sensitivity of both serology and biopsy 1
- May require gluten challenge for accurate diagnosis
Relying solely on IgA-based tests
- IgA deficiency occurs in 2-3% of celiac patients
- Can lead to false negative results 1
Inadequate biopsy sampling
- Patchy nature of celiac disease requires multiple samples
- Insufficient samples may miss affected areas 1
Monitoring limitations
- Serologic tests have low sensitivity (<50%) for detecting persistent villous atrophy in patients on gluten-free diet 4
- Normal antibody levels don't guarantee mucosal healing
Non-celiac gluten sensitivity
- Should only be considered after celiac disease and wheat allergy have been ruled out
- Diagnosis requires negative celiac serology, normal duodenal biopsies, improvement on gluten-free diet, and symptom recurrence with gluten challenge 1
By following this structured approach to diagnosis and treatment, celiac disease can be effectively identified and managed, improving quality of life and preventing complications.